Singapore
Industry
French firm Servier has launched Coralan (ivabradine) in Singapore for the treatment of angina. Because of the city state's affluence and the increasing burden of cardiovascular disease,...
2008-08-13Industry
The National Healthcare Group (NHG) of hospitals in Singapore has contracted local real-time systems provider TCM-RFiD to help pharmacists, nurses and doctors keep track of pharmaceuticals...
2008-02-04Companies
Driven by increasing global demand for medicines, the export of pharmaceuticals from Singapore increased dramatically in March 2007. The trade figures have been welcomed by the country's...
2007-04-18Companies
BMI has reaffirmed its encouraging prospects for Singapore's biomedical sector after UK-based GlaxoSmithKline (GSK) announced that a clinical candidate will emerge from the Biopolis...
2007-03-13Companies
With no national debt and the economy growing at 6.3% in 2006, according to BMI forecasts, Singapore is able to invest around US$25- US$30mn on average per year in stem cell research....
2007-01-03Companies
Singapore has completed the first phase of its Biomedical Science (BMS) initiative, and is keen to push on to phase II, which will have government investment of US$1.4bn. Under the...
2006-11-24Companies
UK-based drugmaker GlaxoSmithKline (GSK) has indicated that in future it will be conducting more of its R&D in Asia, with Singapore and India looking like the company's favoured...
2006-11-20Companies
Singapore's volatile pharmaceutical exports sector rose by 60% in September, according to United Overseas Bank (UOB), boosted by strong demand in Europe. Pharmaceuticals are a key...
2006-10-19




